
Olmezit H 12.5mg/40mg Tablet
Marketer
Zither Pharmaceutical Pvt Ltd
Salt Composition
Hydrochlorothiazide (12.5mg) + Olmesartan Medoxomil (40mg)
Overview Olmezit H 12.5mg/40mg Tablet
Cardiovasc Duo 12.5mg/40mg tablets combine two active ingredients to manage hypertension through complementary mechanisms. Untreated hypertension significantly increases the risk of cardiovascular events such as stroke, myocardial infarction, and renal failure. Cardiovasc Duo can be taken with or without food; dosage is individualized based on your response and health status. Consistent daily dosing is crucial for efficacy. Continue treatment as directed by your physician; discontinuation increases stroke and heart attack risk. This medication includes a diuretic, increasing urination, so avoid taking it within four hours of bedtime. Regular use, even when feeling well, is essential for optimal blood pressure control, as hypertension often lacks noticeable symptoms. Dizziness is the most common adverse event; others include fatigue, headache, weakness, chest pain, and swelling. Increased urination is a medication effect, not a side effect. While rare, other side effects are possible. Elevated intraocular pressure, potentially causing irreversible vision impairment if untreated, is a less frequent complication. Consult the patient information leaflet and discuss any persistent or bothersome side effects with your doctor; dose adjustment or alternative therapy may be considered. This medication is contraindicated in pregnancy and lactation. Patients with hepatic or renal impairment, cardiac disease, or diabetes should consult their physician before initiating therapy. Alcohol consumption may exacerbate hypotensive effects and increase the risk of adverse reactions.
Primary Ingredients of Olmezit H 12.5mg/40mg Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Olmezit H 12.5mg/40mg Tablet
Elevated blood pressure
Major Benefits of Olmezit H 12.5mg/40mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Swallow the Olmezit H 12.5mg/40mg tablet whole; do not crush, chew, or break it. While it can be taken with or without food, consistent timing is recommended for optimal results.
Common Side effects of Olmezit H 12.5mg/40mg Tablet:
- Dizziness
- Weakness
- Tiredness
- Edema (swelling)
- Chest pain
- Upper respiratory tract infection
- Headache
- Increased triglyceride level in blood
- Increased uric acid level in blood
- Abdominal pain
- Back pain
- Skeletal pain
- Blood in urine
- Increased liver enzymes
- Increased blood urea
How to use Olmezit H 12.5mg/40mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Olmezit H 12.5mg/40mg tablet whole; avoid chewing, crushing, or breaking it. While you can take it with or without food, consistent timing is recommended.
How Olmezit H 12.5mg/40mg Tablet works:
Each Olmezit H 12.5mg/40mg tablet contains a dual medication formulation.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Olmezit H 12.5mg/40mg tablets and alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Use of Olmezit H 12.5mg/40mg tablets is contraindicated during pregnancy due to confirmed risks to fetal development. In exceptional, life-threatening circumstances, a physician may consider its use if the potential benefits outweigh the inherent dangers. Medical advice is essential.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Olmezit H 12.5mg/40mg tablets safely. Available human data indicates minimal infant risk associated with this medication.
DrivingUNSAFE
Taking Olmezit H 12.5mg/40mg tablets might cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when taking Olmezit H 12.5mg/40mg tablets. Dosage modification may be necessary; physician consultation is recommended. Routine blood pressure checks are advised to guide dosage adjustments.
LiverCAUTION
Patients with liver impairment should use Olmezit H 12.5mg/40mg tablets cautiously, as dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Olmezit H 12.5mg/40mg Tablet :
Should you forget to take your Olmezit H 12.5mg/40mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Olmezit H 12.5mg/40mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
